Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 41,800 INO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 41,800 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,167 | n/a |
| May 22, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 2,917 | n/a |
| May 16, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,166 | n/a |
| May 16, 2023 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 19,000 | n/a |
| May 17, 2022 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 18,000 | n/a |
| Mar 22, 2022 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 4,273 | n/a |
| Jun 17, 2021 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,858 | n/a |
| Jun 11, 2021 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 12,874 | $147.2K |
| May 17, 2021 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 8,700 | n/a |